Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322
Clinical trial NCT07312799 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07312799
- Sponsor
- Addpharma Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-27
- Primary completion
- 2026-02-11
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.